换一批Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager.
第一作者：
Anna,Wing
第一单位：
Center for Cellular Immunotherapies, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
作者：
医学主题词
动物(Animals);抗体, 双特异性(Antibodies, Bispecific);细胞, 培养的(Cells, Cultured);综合疗法(Combined Modality Therapy);HCT116细胞(HCT116 Cells);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);小鼠(Mice);小鼠, 近交NOD(Mice, Inbred NOD);小鼠, SCID(Mice, SCID);小鼠, 转基因(Mice, Transgenic);肿瘤(Neoplasms);溶瘤病毒疗法(Oncolytic Virotherapy);溶瘤病毒(Oncolytic Viruses);T淋巴细胞(T-Lymphocytes);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/2326-6066.CIR-17-0314
PMID
29588319
发布时间
2024-10-20
- 浏览3
Cancer immunology research
2018年6卷5期
605-616页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
